Inflammatory Bowel Disease Burden in the Middle East and North Africa Region: a Comprehensive Analysis of Incidence, Prevalence, and Mortality from 1990-2019

Overview

Journal Ann Gastroenterol

Specialty Gastroenterology

Date 2024 Sep 6

PMID 39238799

Authors

Saqr Alsakarneh

Mohamed Ahmed

Fouad Jaber

Mohammad Abuassi

Fadi H Mourad

Fadi F Francis

Kassem Barada

Rami Tfayli

Badr Al-Bawardy

Francis A Farraye

Jana G Hashash

Affiliations

Soon will be listed here.

Abstract

Background: The epidemiology of inflammatory bowel disease (IBD) has changed rapidly in recent years. Objective data concerning the IBD burden in the Middle East and North Africa (MENA) region is limited. We aimed to provide a systematic report on the IBD burden in the MENA region. Additionally, we aimed to study the age- and sex-specific trends in IBD incidence, prevalence and mortality rates from 1990-2019.

Methods: Using the Global Burden of Disease (GBD) 2019 Study Database, we investigated the changes in incidence, prevalence and mortality rate, and disability-adjusted life-years (DALYs), at a regional and country level between 1990 and 2019.

Results: In 2019, there were 282,534 cases (95% confidence interval [CI] 239,506-334,478) of IBD in the MENA region (50.5% male). There was an overall increase in the incidence and prevalence rates of IBD in the MENA region from 1990 to 2019, while a simultaneous decrease in overall mortality rates was identified. Incidence rates were highest in Jordan, at 6.9 (95%CI 5.8-8.1) per 100,000, and lowest in Morocco, at 1.6 (95%CI 1.4-2) per 100,000. From 1990-2019, the incidence was found increased in males at a higher rate than in females. The age-standardized mortality rate decreased for both sexes by 24% from 1990-2019.

Conclusion: The trends and geographic variations in IBD within the MENA region provide policymakers with vital information for making informed decisions in policy, research, and investment, thereby enabling the development of more effective strategies and better allocation of resources.

Citing Articles

Evaluating the Efficacy of Probiotics on Disease Progression, Quality of Life, and Nutritional Status Among Patients with Crohn's Disease: A Multicenter, Randomized, Single-Blinded Controlled Trial.

Hoteit M, Hellani M, Karaja M, Zayour N, Sadek Z, Hotayt B Nutrients. 2025; 17(4).

PMID: 40005035 PMC: 11858769. DOI: 10.3390/nu17040708.

Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization.

Yang W, Cui M, Yang P, Liu C, Han X, Yao W Sci Rep. 2025; 15(1):514.

PMID: 39747467 PMC: 11696716. DOI: 10.1038/s41598-024-84116-6.

References

Hausmann J, Blumenstein I . [Gender differences and inflammatory bowel disease]. Z Gastroenterol. 2015; 53(8):774-8. DOI: 10.1055/s-0035-1553499. View

Farrukh A, Mayberry J . Epidemiology of inflammatory bowel disease in the Middle East--an opportune time. Arab J Gastroenterol. 2014; 15(3-4):163-5. DOI: 10.1016/j.ajg.2014.10.001. View

Alsakarneh S, Jaber F, Beran A, Aldiabat M, Abboud Y, Hassan N . The National Burden of Colorectal Cancer in the United States from 1990 to 2019. Cancers (Basel). 2024; 16(1). PMC: 10778178. DOI: 10.3390/cancers16010205. View

Singh S, Qian A, Nguyen N, Ho S, Luo J, Jairath V . Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016. Inflamm Bowel Dis. 2021; 28(3):364-372. PMC: 8889287. DOI: 10.1093/ibd/izab074. View

Su H, Gupta V, Day A, Gearry R . Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand. Inflamm Bowel Dis. 2016; 22(9):2238-44. DOI: 10.1097/MIB.0000000000000829. View

Hodges P, Kelly P . Inflammatory bowel disease in Africa: what is the current state of knowledge?. Int Health. 2020; 12(3):222-230. PMC: 7320423. DOI: 10.1093/inthealth/ihaa005. View

Mosli M, Alawadhi S, Hasan F, Abou Rached A, Sanai F, Danese S . Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-Analysis. Inflamm Intest Dis. 2021; 6(3):123-131. PMC: 8527904. DOI: 10.1159/000518003. View

Zhao M, Gonczi L, Lakatos P, Burisch J . The Burden of Inflammatory Bowel Disease in Europe in 2020. J Crohns Colitis. 2021; 15(9):1573-1587. DOI: 10.1093/ecco-jcc/jjab029. View

Shivashankar R, Tremaine W, Harmsen W, Loftus Jr E . Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010. Clin Gastroenterol Hepatol. 2016; 15(6):857-863. PMC: 5429988. DOI: 10.1016/j.cgh.2016.10.039. View

10.

Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P, Jess T . Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis. 2009; 16(2):347-53. DOI: 10.1002/ibd.21007. View

11.

. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1250-1284. PMC: 7562819. DOI: 10.1016/S0140-6736(20)30750-9. View

12.

Xu F, Carlson S, Liu Y, Greenlund K . Prevalence of Inflammatory Bowel Disease Among Medicare Fee-For-Service Beneficiaries - United States, 2001-2018. MMWR Morb Mortal Wkly Rep. 2021; 70(19):698-701. PMC: 8118152. DOI: 10.15585/mmwr.mm7019a2. View

13.

Zeng Z, Zhu Z, Yang Y, Ruan W, Peng X, Su Y . Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study. J Gastroenterol Hepatol. 2013; 28(7):1148-53. DOI: 10.1111/jgh.12164. View

14.

Esmat S, El Nady M, Elfekki M, ElSherif Y, Naga M . Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt. World J Gastroenterol. 2014; 20(3):814-21. PMC: 3921490. DOI: 10.3748/wjg.v20.i3.814. View

15.

Selinger C, Leong R . Mortality from inflammatory bowel diseases. Inflamm Bowel Dis. 2012; 18(8):1566-72. DOI: 10.1002/ibd.22871. View

16.

Olfatifar M, Zali M, Pourhoseingholi M, Balaii H, Ghavami S, Ivanchuk M . The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study. BMC Gastroenterol. 2021; 21(1):204. PMC: 8101120. DOI: 10.1186/s12876-021-01745-1. View

17.

Cosnes J, Gower-Rousseau C, Seksik P, Cortot A . Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011; 140(6):1785-94. DOI: 10.1053/j.gastro.2011.01.055. View

18.

Lungaro L, Costanzini A, Manza F, Barbalinardo M, Gentili D, Guarino M . Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review. J Pers Med. 2023; 13(2). PMC: 9958616. DOI: 10.3390/jpm13020165. View

19.

King J, Underwood F, Panaccione N, Quan J, Windsor J, Kotze P . Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development. Lancet Gastroenterol Hepatol. 2019; 4(4):287-295. DOI: 10.1016/S2468-1253(19)30013-5. View

20.

Zahedi M, Darvish Moghadam S, Hayat Bakhsh Abbasi M, Dehghani M, Shafiei Pour S, Zydabady Nejad H . The incidence rate of inflammatory bowel disease in an urban area of iran: a developing country. Middle East J Dig Dis. 2014; 6(1):32-6. PMC: 4005476. View